Alfred Sandrock Insider Trading for February 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Alfred Sandrock.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Alfred Sandrock for February 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Sell | S | 261.90 | 183 | 47,928 | 7,990 | 8.2 K to 8 K (-2.24 %) |
| Feb 25 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | J | 0.00 | 689 | 0 | 2,074 | |
| Feb 25 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | M | 0.00 | 347 | 0 | 2,763 | |
| Feb 25 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 258.99 | 164 | 42,474 | 8,173 | 8.3 K to 8.2 K (-1.97 %) |
| Feb 25 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Buy | M | 0.00 | 347 | 0 | 8,337 | 8 K to 8.3 K (+4.34 %) |
| Feb 24 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | A | 0.00 | 7,270 | 0 | 7,270 | |
| Feb 19 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Sell | S | 256.16 | 722 | 184,948 | 7,990 | 8.7 K to 8 K (-8.29 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | J | 0.00 | 1,900 | 0 | 10,006 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | J | 0.00 | 759 | 0 | 1,336 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | M | 0.00 | 792 | 0 | 797 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | M | 0.00 | 573 | 0 | 2,095 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | M | 0.00 | 1,434 | 0 | 11,906 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 247.22 | 373 | 92,213 | 8,712 | 9.1 K to 8.7 K (-4.11 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Buy | M | 0.00 | 792 | 0 | 9,085 | 8.3 K to 9.1 K (+9.55 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 247.22 | 270 | 66,749 | 8,293 | 8.6 K to 8.3 K (-3.15 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Buy | M | 0.00 | 573 | 0 | 8,563 | 8 K to 8.6 K (+7.17 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 247.22 | 556 | 137,454 | 7,990 | 8.5 K to 8 K (-6.51 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Buy | M | 0.00 | 1,434 | 0 | 8,546 | 7.1 K to 8.5 K (+20.16 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 247.22 | 628 | 155,254 | 7,112 | 7.7 K to 7.1 K (-8.11 %) |
| Feb 10 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | M | 0.00 | 1,278 | 0 | 0 | |
| Feb 10 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Sell | S | 246.54 | 852 | 210,052 | 7,740 | 8.6 K to 7.7 K (-9.92 %) |
| Feb 10 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 250.77 | 426 | 106,828 | 8,592 | 9 K to 8.6 K (-4.72 %) |
| Feb 10 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Buy | M | 0.00 | 1,278 | 0 | 9,018 | 7.7 K to 9 K (+16.51 %) |